{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:10:12Z","timestamp":1772896212684,"version":"3.50.1"},"publisher-location":"Dordrecht","reference-count":76,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789401772143","type":"print"},{"value":"9789401772150","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-94-017-7215-0_12","type":"book-chapter","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T07:05:41Z","timestamp":1446534341000},"page":"179-193","source":"Crossref","is-referenced-by-count":21,"title":["Biomarkers for Hepatocellular Carcinoma (HCC): An Update"],"prefix":"10.1007","author":[{"given":"Dave","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Satomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89\u201395","journal-title":"Clin Pharmacol Ther"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0009-8981(01)00644-1","volume":"313","author":"D Li","year":"2001","unstructured":"Li D, Mallory T, Satomura S (2001) AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta 313:15\u201319","journal-title":"Clin Chim Acta"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/hep.1840180434","volume":"18","author":"IC Weitz","year":"1993","unstructured":"Weitz IC, Liebman HA (1993) Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. Hepatology 18:990\u2013997","journal-title":"Hepatology"},{"issue":"6","key":"12_CR4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2012.02.009","volume":"148","author":"R Chen","year":"2012","unstructured":"Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R et al (2012) Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148(6):1293\u20131307","journal-title":"Cell"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12014-010-9049-9","volume":"6","author":"DJ Li","year":"2010","unstructured":"Li DJ, Chan DW (2010) Decoding the protein folding pattern of serum biomarkers: alternative strategy for cancer biomarker validation? Clin Proteom 6:53\u201355","journal-title":"Clin Proteom"},{"key":"12_CR6","volume-title":"Hepatitis and liver cancer a national strategy for prevention and control hepatitis B and C","author":"Institute of Medicine of National Academies","year":"2010","unstructured":"Institute of Medicine of National Academies (2010) Hepatitis and liver cancer a national strategy for prevention and control hepatitis B and C. The National Academies Press, Washington, DC"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","volume":"136","author":"JE Everhart","year":"2009","unstructured":"Everhart JE, Ruhl CE (2009) Burden of digestive diseases in the United States Part III: overall and upper gastrointestinal diseases. Gasteroenterology 136:1134\u20131144","journal-title":"Gasteroenterology"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0030-1247128","volume":"30","author":"M Sherman","year":"2010","unstructured":"Sherman M (2010) Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 30:3\u201316","journal-title":"Semin Liver Dis"},{"key":"12_CR9","first-page":"2259","volume":"44","author":"GH Heppner","year":"1984","unstructured":"Heppner GH (1984) Tumor heterogeneity. Cancer Res 44:2259\u20132265","journal-title":"Cancer Res"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cell.2010.04.033","volume":"141","author":"SJ Altschuler","year":"2010","unstructured":"Altschuler SJ, Wu LF (2010) Cellular heterogeneity: do differences make a difference? Cell 141:559\u2013563","journal-title":"Cell"},{"key":"12_CR11","first-page":"105","volume":"1805","author":"A Marusky","year":"2010","unstructured":"Marusky A, Polyak K (2010) Tumor heterogeneity: cause and consequence. Biochim Biophys Acta 1805:105\u2013117","journal-title":"Biochim Biophys Acta"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cell.2010.03.032","volume":"141","author":"J McClenllan","year":"2010","unstructured":"McClenllan J, King M-C (2010) Genetic heterogeneity in human disease. Cell 141:210\u2013217","journal-title":"Cell"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","volume":"365","author":"H El-Serag","year":"2011","unstructured":"El-Serag H (2011) Hepatocellular carcinoma. N Engl J Med 365:1118\u20131127","journal-title":"N Engl J Med"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.cld.2011.03.003","volume":"15","author":"M Sherman","year":"2011","unstructured":"Sherman M (2011) Hepatocellular carcinoma: screening and staging. Clin Liver Dis 15:323\u2013334","journal-title":"Clin Liver Dis"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"JG Bruix","year":"2005","unstructured":"Bruix JG, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208\u20131236","journal-title":"Hepatology"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1258\/096914103771773320","volume":"10","author":"JG Chen","year":"2003","unstructured":"Chen JG, Parkin DM, Chen QG, Lu JH, Shen QJ, Zhang BC, Zhu YR (2003) Screening for liver cancer: results of randomized controlled trial in Qidong, China. J Med Screen 10:204\u2013209","journal-title":"J Med Screen"},{"key":"12_CR17","first-page":"417","volume":"130","author":"BH Zhang","year":"2004","unstructured":"Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130:417\u2013422","journal-title":"J Cancer Res Clin Oncol"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1136\/gut.2010.230508","volume":"60","author":"HB El-Serag","year":"2011","unstructured":"El-Serag HB, Kramer JR, Chen GH, Duan Z, Richardson PA, Davila JA (2011) Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut 60:992\u2013997","journal-title":"Gut"},{"issue":"suppl. 1","key":"12_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000315234","volume":"78","author":"N Izumi","year":"2010","unstructured":"Izumi N (2010) Diagnostic and treatment algorithm of the Japanese Society of Hepatology: a consensus-based practice guideline. Oncology 78(suppl 1):78\u201386","journal-title":"Oncology"},{"issue":"7","key":"12_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1478-3231.2012.02792.x","volume":"32","author":"P Song","year":"2012","unstructured":"Song P, Tobe RG, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, Tang W (2012) The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver Int 32(7):1053\u20131063. doi:10.1111\/j.1478-3231.2012.02792.x","journal-title":"Liver Int"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.amjmed.2007.09.020","volume":"121","author":"RT Stravitz","year":"2008","unstructured":"Stravitz RT, Heuman DM, Chand N, Sterling RK, Shiffman ML, Luketic VA, Sanyal AJ, Habib A, Mihas AA, Giles HC, Maluf DG, Cotterell AH, Posner MP, Fisher RA (2008) Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome. Am J Med 121:119\u2013126","journal-title":"Am J Med"},{"issue":"1","key":"12_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jamcollsurg.2012.02.022","volume":"215","author":"MB Doyle","year":"2012","unstructured":"Doyle MB, Vachharajani N, Maynard E, Shenoy S, Anderson C, Wellen JR, Lowell JA, Chapman WC (2012) Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent Outcomes. J Am Coll Surg 215(1):19\u201328","journal-title":"J Am Coll Surg"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1572-0241.2006.00467.x","volume":"10","author":"A Colli","year":"2006","unstructured":"Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, Duca P (2006) Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 10:513\u2013523","journal-title":"Am J Gastroenterol"},{"key":"12_CR24","first-page":"821","volume":"7","author":"JA Marrero","year":"2011","unstructured":"Marrero JA (2011) The role of serum biomarkers in hepatocellular carcinoma surveillance. Gastroenterol Hepatol 7:821\u2013823","journal-title":"Gastroenterol Hepatol"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00261-011-9685-1","volume":"36","author":"O Matsui","year":"2011","unstructured":"Matsui O, Kobayashi S, Sanada J, Kouda W, Ryu Y, Kozaka K, Kitao A, Nakamura K, Gabata T (2011) Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 36:264\u2013272","journal-title":"Abdom Imaging"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0168-8278(99)80016-6","volume":"30","author":"T Kumada","year":"1999","unstructured":"Kumada T, Nakano S, Takeda I, Kiriyama S, Sone Y, Hayashi K, Katoh H, Endoh T, Sassa T, Satomura S (1999) Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J Hepatol 30:125\u2013130","journal-title":"J Hepatol"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1478-3231.2005.01111.x","volume":"25","author":"T Tada","year":"2005","unstructured":"Tada T, Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kitabatake S, Kuzuya T, Nonogaki K, Shimizu J, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J, Satomura S (2005) Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Liver Int 25:848\u2013853","journal-title":"Liver Int"},{"issue":"suppl. 1","key":"12_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000333252","volume":"81","author":"M Kudo","year":"2011","unstructured":"Kudo M (2011) Hepatocellular carcinoma in 2011 and beyond: from the pathogenesis to molecular targeted therapy. Oncology 81(suppl 1):1\u201310","journal-title":"Oncology"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cgh.2008.08.041","volume":"7","author":"RK Sterling","year":"2009","unstructured":"Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, Kanke F, Schwartz ME, Sherman M (2009) Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol 7:104\u2013113","journal-title":"Clin Gastroenterol Hepatol"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S1542-3565(05)00855-4","volume":"4","author":"H Toyoda","year":"2006","unstructured":"Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J (2006) Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 4:111\u2013117","journal-title":"Clin Gastroenterol Hepatol"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jhep.2010.02.006","volume":"52","author":"M Sherman","year":"2010","unstructured":"Sherman M (2010) The resurrection of alphafetoprotein. J Hepatol 52:939\u2013940","journal-title":"J Hepatol"},{"key":"12_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ab.2009.02.030","volume":"388","author":"C Kagebayashi","year":"2009","unstructured":"Kagebayashi C, Yamaguchi I, Akinaga A, Kitano H, Yokoyama K, Satomura M, Kurosawa T, Watanabe M, Kawabata T, Chang W, Li C, Bousse L, Wada HG, Satomura S (2009) Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis. Anal Biochem 388:306\u2013311","journal-title":"Anal Biochem"},{"key":"12_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cld.2011.03.010","volume":"15","author":"C Frenette","year":"2011","unstructured":"Frenette C, Gish RG (2011) Hepatocellular carcinoma: molecular and genomic guideline for the clinician. Clin Liver Dis 15:307\u2013321","journal-title":"Clin Liver Dis"},{"key":"12_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/00365513.2010.493387","volume":"242","author":"Z Feng","year":"2010","unstructured":"Feng Z (2010) Classification versus association models: should the same methods apply? Scand J Clin Lab Invest Suppl 242:53\u201358","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"12_CR35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/CBM-2007-3202","volume":"3","author":"ML Volk","year":"2007","unstructured":"Volk ML, Hernandez JC, Su GL, Lok AS, Marrero JA (2007) Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark 3:79\u201387","journal-title":"Cancer Biomark"},{"key":"12_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1440-1746.2010.06585.x","volume":"26","author":"T Hanaoka","year":"2011","unstructured":"Hanaoka T, Sato S, Tobita H, Miyake T, Ishihara S, Akagi S, Amano Y, Kinoshita Y (2011) Clinical significance of the highly sensitive fucosylated fraction of \u03b1-fetoprotein in patients with chronic liver disease. J Gastroenterol Hepatol 26:739\u2013744","journal-title":"J Gastroenterol Hepatol"},{"key":"12_CR37","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","volume":"93","author":"MS Pepe","year":"2001","unstructured":"Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93:1054\u20131061","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 5","key":"12_CR38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2011.0137","volume":"9","author":"PG Febbo","year":"2011","unstructured":"Febbo PG, Ladanyi M, Aldape KD, De Marzo AM, Hammond ME, Hayes DF, Iafrate AJ, Kelley RK, Marcucci G, Ogino S, Pao W, Sgroi DC, Birkeland ML (2011) NCCN Task Force report: evaluating the clinical utility of tumor markers in oncology. J Natl Compr Canc Netw 9(Suppl 5):S1\u2013S32","journal-title":"J Natl Compr Canc Netw"},{"key":"12_CR39","volume-title":"Evidence-based diagnosis","year":"2009","unstructured":"Newman TB, Kohn MA (eds) (2009) Evidence-based diagnosis. Cambridge University Press, New York"},{"issue":"20","key":"12_CR40","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/jnci\/djn326","volume":"100","author":"MS Pepe","year":"2008","unstructured":"Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD (2008) Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst 100(20):1432\u20131438","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"12_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000315223","volume":"78","author":"M Sherman","year":"2010","unstructured":"Sherman M (2010) Epidemiology of hepatocellular carcinoma. Oncology 78(Suppl 1):7\u201310","journal-title":"Oncology"},{"issue":"Suppl 3","key":"12_CR42","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1016\/S1590-8658(10)60507-5","volume":"42","author":"H Nordenstedt","year":"2010","unstructured":"Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42(Suppl 3):S206\u2013S214","journal-title":"Dig Liver Dis"},{"key":"12_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/hep.24397","volume":"54","author":"TM Welzel","year":"2011","unstructured":"Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA (2011) Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 54:463\u2013471","journal-title":"Hepatology"},{"key":"12_CR44","unstructured":"Curley SA, Barnett CC Jr, Abdalla EK (2010) Staging and prognostic factors in hepatocellular carcinoma. UpToDate (Version 18.3: September 2010). http:\/\/www.uptodate.com\/online\/content\/topic.do?topicKey+gicancer\/12573&view=print. Accessed Jan 2011"},{"key":"12_CR45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1477-2574.2009.00070.x","volume":"11","author":"H Nathan","year":"2009","unstructured":"Nathan H, Mentha G, Marques HP, Capussotti L, Majno P, Aldrighetti L, Pulitano C, Rubbia-Brandt L, Russolillo N, Philosophe B, Barroso E, Ferrero A, Schulick RD, Choti MA, Pawlik TM (2009) Comparative performances of staging systems for early hepatocellular carcinoma. HPB (Oxford) 11:382\u2013390","journal-title":"HPB (Oxford)"},{"key":"12_CR46","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845\u2013867","journal-title":"Mol Cell Proteomics"},{"key":"12_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1559-0275-8-7","volume":"8","author":"DL Meany","year":"2011","unstructured":"Meany DL, Chan DW (2011) Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin Proteomics 8:7\u201314","journal-title":"Clin Proteomics"},{"key":"12_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/jb\/mvn011","volume":"143","author":"E Miyoshi","year":"2008","unstructured":"Miyoshi E, Moriwaki K, Nakagawa T (2008) Biological function of fucosylation in cancer biology. J Biochem 143:725\u2013729","journal-title":"J Biochem"},{"key":"12_CR49","doi-asserted-by":"publisher","first-page":"15721","DOI":"10.1073\/pnas.0507659102","volume":"102","author":"H Schachter","year":"2005","unstructured":"Schachter H (2005) The search for glycan function: fucosylation of the TGF-beta1 receptor is required for receptor activation. Proc Natl Acad Sci U S A 102:15721\u201315722","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR50","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1021\/pr100414r","volume":"9","author":"T Nakagawa","year":"2010","unstructured":"Nakagawa T, Takeishi S, Kameyama A, Yagi H, Yoshioka T, Moriwaki K, Masuda T, Matsumoto H, Kato K, Narimatsu H, Taniguchi N, Miyoshi E (2010) Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis. J Proteome Res 9:4888\u20134896","journal-title":"J Proteome Res"},{"key":"12_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1440-1746.2005.03773.x","volume":"20","author":"H Okuda","year":"2005","unstructured":"Okuda H, Saito A, Shiratori K, Yamamoto M, Takasaki K, Nakano M (2005) Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3. J Gastroenterol Hepatol 20:759\u2013764","journal-title":"J Gastroenterol Hepatol"},{"key":"12_CR52","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1046\/j.1440-1746.2002.02806.x","volume":"17","author":"H Okuda","year":"2002","unstructured":"Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M, Takasaki K, Nakano M (2002) Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone. J Gastroenterol Hepatol 17:772\u2013778","journal-title":"J Gastroenterol Hepatol"},{"key":"12_CR53","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1440-1746.2006.04257.x","volume":"21","author":"H Okuda","year":"2006","unstructured":"Okuda H, Shiratori K, Yamamoto M, Takasaki K, Nakano M (2006) Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 21:869\u2013873","journal-title":"J Gastroenterol Hepatol"},{"key":"12_CR54","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1056\/NEJM198405313102204","volume":"310","author":"HA Liebman","year":"1984","unstructured":"Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD, Coleman MS, Furie B (1984) Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310:1427\u20131431","journal-title":"N Engl J Med"},{"issue":"10","key":"12_CR55","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/j.1440-1746.2012.07173.x","volume":"27","author":"M Matsubara","year":"2012","unstructured":"Matsubara M, Shiraha H, Kataoka J, Iwamuro M, Horiguchi S, Nishina SI, Takaoka N, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yamamoto K (2012) Des-\u03b3-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma. J Gastroenterol Hepatol 27(10):1602\u20131608. doi:10.1111\/j.1440-1746.2012.07173.x","journal-title":"J Gastroenterol Hepatol"},{"key":"12_CR56","first-page":"269","volume":"12","author":"LW Yuan","year":"2004","unstructured":"Yuan LW, Tang W, Kokudo N, Sugawara Y, Karako H, Hasegawa K, Aoki T, Kyoden Y, Deli G, Li YG, Makuuchi M (2004) Measurement of des-gamma-carboxy prothrombin levels in cancer and non-cancer tissue in patients with hepatocellular carcinoma. Oncol Rep 12:269\u2013273","journal-title":"Oncol Rep"},{"key":"12_CR57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1478-3231.2010.02348.x","volume":"31","author":"Y Inagaki","year":"2011","unstructured":"Inagaki Y, Tang W, Makuuchi M, Hasegawa K, Sugawara Y, Kokudo N (2011) Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-\u03b3-carboxyprothrombin. Liver Int 31:22\u201335","journal-title":"Liver Int"},{"key":"12_CR58","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1440-1746.2008.05395.x","volume":"23","author":"FA Durazo","year":"2008","unstructured":"Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ (2008) Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 23:1541\u20131548","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"12_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bpg.2004.10.003","volume":"19","author":"MF Yuen","year":"2005","unstructured":"Yuen MF, Lai CL (2005) Serological markers of liver cancer. Best Pract Res Clin Gastroenterol 19(1):91\u201399","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"12_CR60","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s00535-007-2117-x","volume":"42","author":"H Miyaaki","year":"2007","unstructured":"Miyaaki H, Nakashima O, Kurogi M, Eguchi K, Kojiro M (2007) Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol 42:962\u2013968","journal-title":"J Gastroenterol"},{"key":"12_CR61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0009-8981(02)00305-4","volume":"327","author":"Y Yamagata","year":"2003","unstructured":"Yamagata Y, Shimizu K, Nakamura K, Henmi F, Satomura S, Matsuura S, Tanaka M (2003) Simultaneous determination of percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein and alpha-fetoprotein concentration using the LiBASys clinical auto-analyzer. Clin Chim Acta 327:59\u201367","journal-title":"Clin Chim Acta"},{"key":"12_CR62","first-page":"306","volume":"388","author":"C Kagebayashi","year":"2009","unstructured":"Kagebayashi C, Yamaguchi I, Akinaga A, Kitano H, Yokoyama K, Satomura M, Kurosawa T, Watanabe M, Kawabata T, Chang W, Li C, Bousse L, Wada HG, Satomura S (2009) Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresisAnal. Biomolecules 388:306\u2013311","journal-title":"Biomolecules"},{"key":"12_CR63","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/elps.200700898","volume":"29","author":"T Kawabata","year":"2008","unstructured":"Kawabata T, Wada HG, Watanabe M, Satomura S (2008) Electrokinetic analyte transport assay for alpha-fetoprotein immunoassay integrates mixing, reaction and separation on-chip. Electrophoresis 29:1399\u20131406","journal-title":"Electrophoresis"},{"key":"12_CR64","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJM198005153022003","volume":"302","author":"SG Pauker","year":"1980","unstructured":"Pauker SG, Kassirer JP (1980) The threshold approach to clinical decision making. N Engl J Med 302:1109\u20131117","journal-title":"N Engl J Med"},{"key":"12_CR65","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1007\/s10620-010-1222-5","volume":"55","author":"Y Tamura","year":"2010","unstructured":"Tamura Y, Igarashi M, Kawai H, Suda T, Satomura S, Aoyagi Y (2010) Clinical advantage of highly sensitive on-chip immunoassay for fucosylated fraction of alpha-fetoprotein in patients with hepatocellular carcinoma. Dig Dis Sci 55:3576\u20133583","journal-title":"Dig Dis Sci"},{"key":"12_CR66","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1349-7006.2011.01875.x","volume":"102","author":"H Toyoda","year":"2011","unstructured":"Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, Kanke F, Satomura S (2011) Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng\/mL. Cancer Sci 102:1025\u20131031","journal-title":"Cancer Sci"},{"issue":"Suppl 1","key":"12_CR67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000333263","volume":"81","author":"H Toyoda","year":"2011","unstructured":"Toyoda H, Kumada T, Tada T (2011) Highly sensitive Lens culinaris agglutinin-reactive \u03b1-fetoprotein: a new tool for the management of hepatocellular carcinoma. Oncology 81(Suppl 1):61\u201365","journal-title":"Oncology"},{"key":"12_CR68","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1200\/JCO.2010.28.7805","volume":"28","author":"MB Thomas","year":"2010","unstructured":"Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, Gores G, Kerlan R, Merle P, O\u2019Neil B, Poon R, Schwartz L, Tepper J, Yao F, Haller D, Mooney M, Venook A (2010) Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol 28:3994\u20134005","journal-title":"J Clin Oncol"},{"key":"12_CR69","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1007\/s10620-010-1184-7","volume":"55","author":"G Malaguarnera","year":"2010","unstructured":"Malaguarnera G, Giordano M, Paladina I, Berretta M, Cappellani A, Malaguarnera M (2010) Serum markers of hepatocellular carcinoma. Dig Dis Sci 55:2744\u20132755","journal-title":"Dig Dis Sci"},{"key":"12_CR70","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/hep.24703","volume":"55","author":"S Shang","year":"2012","unstructured":"Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, Sangrajrang S, Hainaut P, Marrero JA, Beretta L (2012) Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology 55:483\u2013490","journal-title":"Hepatology"},{"key":"12_CR71","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1470-2045(12)70233-4","volume":"13","author":"Q Shen","year":"2012","unstructured":"Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, Wang N, Niu Y, Wu Z, Zhou J, Qiu SJ, Shi YH, Yu B, Tang N, Chu W, Wang M, Wu J, Zhang Z, Yang S, Gu J, Wang H, Qin W (2012) Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol 13:817\u2013826","journal-title":"Lancet Oncol"},{"key":"12_CR72","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1872-034X.2011.00858.x","volume":"41","author":"M Kobayashi","year":"2011","unstructured":"Kobayashi M, Hosaka T, Ikeda K, Seko Y, Kawamura Y, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Kumada H (2011) Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively. Hepatol Res 41:1036\u20131045","journal-title":"Hepatol Res"},{"key":"12_CR73","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.21408","volume":"44","author":"R Tateishi","year":"2006","unstructured":"Tateishi R, Shiina S, Yoshida H, Teratani T, Obi S, Yamashiki N, Yoshida H, Akamatsu M, Kawabe T, Omata M (2006) Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 44:1518\u20131527","journal-title":"Hepatology"},{"key":"12_CR74","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S1076-6332(03)80087-9","volume":"10","author":"KG Moons","year":"2003","unstructured":"Moons KG, Harrell FE (2003) Sensitivity and specificity should be de-emphasized in diagnostic accuracy studies. Acad Radiol 10:670\u2013672","journal-title":"Acad Radiol"},{"key":"12_CR75","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/10543400701668308","volume":"18","author":"MV Kondratovich","year":"2008","unstructured":"Kondratovich MV (2008) Comparing two medical tests when results of reference standard are unavailable for those negative via both tests. J Biopharm Stat 18:145\u2013166","journal-title":"J Biopharm Stat"},{"key":"12_CR76","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/aje\/kwh101","volume":"159","author":"MS Pepe","year":"2004","unstructured":"Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P (2004) Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159:882\u2013890","journal-title":"Am J Epidemiol"}],"container-title":["Advances in Experimental Medicine and Biology","Advances in Cancer Biomarkers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-017-7215-0_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T17:34:40Z","timestamp":1675877680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-017-7215-0_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9789401772143","9789401772150"],"references-count":76,"URL":"https:\/\/doi.org\/10.1007\/978-94-017-7215-0_12","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}